Increase of Apoptosis in a Murine Model for Severe Pneumococcal Pneumonia during Influenza A Virus Infection

被引:1
|
作者
Kosai, Kosuke [2 ]
Seki, Masafumi [1 ,2 ]
Tanaka, Akitaka [2 ]
Morinaga, Yoshitomo [2 ]
Imamura, Yoshifumi [2 ]
Izumikawa, Koichi [2 ]
Kakeya, Hiroshi [2 ]
Yamamoto, Yoshihiro [2 ]
Yanagihara, Katsunori [2 ]
Tomono, Kazunori [1 ]
Kohno, Shigeru [2 ]
机构
[1] Osaka Univ Hosp, Div Infectious Dis & Prevent, Suita, Osaka 5650871, Japan
[2] Nagasaki Univ, Dept Internal Med 2, Nagasaki 8528501, Japan
基金
日本学术振兴会;
关键词
BACTERIAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; DEATH; EXPRESSION; CLEARANCE; INDUCTION; CELLS; MICE; PREPAREDNESS; INFLAMMATION;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The mechanisms of severe pneumonia caused by co-infection of bacteria and influenza A virus (IAV) have not been fully elucidated. We examined apoptosis and inflammatory responses in a murine model for pneumococcal pneumonia during IAV infection. Inflammation, respiratory epithelium apoptosis, and inflammatory-cell infiltration increased in a time dependent manner in the lungs of mice co-infected with Streptococcus pneumoniae and IAV, in comparison with those infected with either S. pneumoniae or IAV. According to appearance of terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cells, caspase-3 and -8 were activated 24 h after S. pneumoniae infection, and caspase-3 activation decreased after 48 h, whereas inflammatory cytokine levels continued to increase in co-infected mice. In contrast, in mice infected with either IAV or S. pneumoniae, apoptosis and activation of factors related to caspase-3 peaked at 48 h. Furthermore, Fas-associated death domain was significantly expressed in the lungs of co-infected mice 24 h after S. pneumoniae infection. These data suggest that early onset of apoptosis and its related factors play important roles in fulminant pneumonia resulting from bacterial pneumonia complicated by co-infection with influenza virus.
引用
收藏
页码:451 / 457
页数:7
相关论文
共 50 条
  • [41] Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection
    Fukuda, Yoshiko
    Furuya, Yuri
    Nozaki, Yusuke
    Takahata, Masahiro
    Nomura, Nobuhiko
    Mitsuyama, Junichi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 78 (02) : 168 - 171
  • [42] Host susceptibility to severe influenza A virus infection
    Clohisey, Sara
    Baillie, John Kenneth
    CRITICAL CARE, 2019, 23 (01)
  • [43] Host susceptibility to severe influenza A virus infection
    Sara Clohisey
    John Kenneth Baillie
    Critical Care, 23
  • [44] Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infection
    Sarah Rosli
    Christopher M. Harpur
    Maggie Lam
    Alison C. West
    Christopher Hodges
    Ashley Mansell
    Kate E. Lawlor
    Michelle D. Tate
    Cell Death & Disease, 14
  • [45] Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infection
    Rosli, Sarah
    Harpur, Christopher M.
    Lam, Maggie
    West, Alison C.
    Hodges, Christopher
    Mansell, Ashley
    Lawlor, Kate E.
    Tate, Michelle D.
    CELL DEATH & DISEASE, 2023, 14 (11)
  • [46] PULMONARY ANTIBACTERIAL DEFENSES DURING MILD AND SEVERE INFLUENZA-VIRUS INFECTION
    NICKERSON, CL
    JAKAB, GJ
    INFECTION AND IMMUNITY, 1990, 58 (09) : 2809 - 2814
  • [47] Outbreaks of influenza B infection and pneumococcal pneumonia at a mental health facility in Japan
    Yamazaki, Yoshitaka
    Goto, Norihiko
    Iwanami, Naoya
    Hama, Mineyuki
    Fujiwara, Noriko
    Takahashi, Yuko
    Sekiguchi, Maki
    Chang, Bin
    Yamazaki, Munehiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (12) : 837 - 840
  • [48] Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
    Melo, Eliza M.
    Del Sarto, Juliana
    Vago, Juliana P.
    Tavares, Luciana P.
    Rago, Flavia
    Goncalves, Ana Paula F.
    Machado, Marina G.
    Aranda-Pardos, Irene
    Valiate, Bruno V. S.
    Cassali, Geovanni D.
    Pinho, Vanessa
    Sousa, Lirlandia P.
    A-Gonzalez, Noelia
    Campagnole-Santos, Maria Jose
    Bader, Michael
    Santos, Robson A. S.
    Machado, Alexandre, V
    Ludwig, Stephan
    Teixeira, Mauro M.
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [49] A Non-Human Primate Model of Severe Pneumococcal Pneumonia
    Reyes, Luis F.
    Restrepo, Marcos I.
    Hinojosa, Cecilia A.
    Soni, Nilam J.
    Shenoy, Anukul T.
    Gilley, Ryan P.
    Gonzalez-Juarbe, Norberto
    Noda, Julio R.
    Winter, Vicki T.
    de la Garza, Melissa A.
    Shade, Robert E.
    Coalson, Jacqueline J.
    Giavedoni, Luis D.
    Anzueto, Antonio
    Orihuela, Carlos J.
    PLOS ONE, 2016, 11 (11):
  • [50] Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model
    Harada, Tatsuhiko
    Ishimatsu, Yuji
    Hara, Atsuko
    Morita, Towako
    Nakashima, Shota
    Kakugawa, Tomoyuki
    Sakamoto, Noriho
    Kosai, Kosuke
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    Kohno, Shigeru
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (03): : 457 - 463